The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,170.00
Ask: 12,174.00
Change: -74.00 (-0.60%)
Spread: 4.00 (0.033%)
Open: 12,240.00
High: 12,306.00
Low: 12,168.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazil eyes July for full local production of AstraZeneca vaccine

Mon, 15th Mar 2021 18:32

By Rodrigo Viga

RIO DE JANEIRO, March 15 (Reuters) - Brazil could begin full
production of AstraZeneca Plc's COVID-19 vaccine by July
if regulators allow, an official at biomedical center Fiocruz
said, moving up by 100 days the timeline to produce shots
without imported ingredients.

Fiocruz Vice President Marco Krieger told Reuters that, if
health regulator Anvisa waives some controls, the biomedical
institute could move up the Sept. 30 target date for 100% local
production of the shot by AstraZeneca and Oxford University.

"This would be important at a time when Brazil is facing
vaccine shortages," Krieger said in an interview on Friday.

Delays in getting supplies from India and China have slowed
Fiocruz's finishing line and Brazil's vaccination program. Only
6% of Brazil's adult population has had their first of two
shots.

Federally funded Fiocruz, based in Rio de Janeiro, has
delivered 4 million ready-made vaccines from India and is
filling and finishing shots with active ingredients from China.
Delivery of those doses, starting this week, is expected to
total 100.4 million by July.

Fully local production of the vaccine is scheduled for
September, when Fiocruz plans to start delivery of 110 million
doses for Brazil's immunization program.

Given the urgent need for vaccines in Brazil, which lost
more than 12,000 lives to the pandemic last week alone, Krieger
said he hoped Anvisa would help to shorten that timeline.

As the vaccine is already in use in Europe and elsewhere,
Krieger said Fiocruz may be able to get Anvisa's approval after
the regulator supervises production of just one batch, rather
than the customary three batches.

Along with the 4 million AstraZeneca doses, Brazil's
government has received 20.6 million doses of CoronaVac, made by
China's Sinovac Biotech Ltd and bottled by Sao Paulo's
Butantan Institute with active ingredients from China.

On Friday, Anvisa granted final approval for AstraZeneca's
vaccine. CoronaVac has been approved for emergency use.

Krieger said output from Fiocruz should reach 1 million
doses a day by the end of March. By then, Fiocruz will have
received another shipment of ingredients from China to make 30
million doses, he said.

Krieger did not address the British vaccine being halted
last week in Denmark, Norway and Iceland over bleeding and
clotting issues.

AstraZeneca said on Sunday a review of safety data of people
vaccinated with its COVID-19 vaccine has shown no evidence of
increased risk of blood clots.
(Reporting by Rodrigo Viga Gaier
Writing by Anthony Boadle; Editing by Richard Chang)

More News
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.